A summary of the key technological advancements in the preparation of antibody-oligonucleotide conjugates (AOCs) and the distinct advantages and disadvantages of AOCs as novel therapeutics are presented. The merits and demerits of the different approaches to conjugating oligonucleotides to antibodies, antibody fragments or other proteins, mainly from the perspective of AOC purification and analytical characterizations, are assessed. The lessons learned from in vitro and in vivo studies, especially the findings related to silencing, trafficking, and cytotoxicity of the conjugates, are also summarized.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922418 | PMC |
| http://dx.doi.org/10.3390/jcm10040838 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Visualization of Protein-Protein Interaction In Situ Using Hybridization-Enhanced Proximity Ligation Assay.
Anal Chem
December 2024
School of Medicine and School of Biomedical Sciences, Huaqiao University, Xiamen, Fujian 361021, China.
Understanding protein-protein interactions (PPIs) is critical for elucidating cellular functions and disease mechanisms. We present the hybridization-enhanced proximity ligation assay (HPLA), a novel approach incorporating a prehybridization step to improve the ligation efficiency of DNA probes on antibody-oligonucleotide conjugates. This step involves a splint probe hybridizing with complementary sequences on the DNA probes bound to interacting protein complexes, forming V-shaped overhangs that facilitate the circularization of two circle probes.
View Article and Find Full Text PDFCorrigendum to "Overcoming limitations and advancing the therapeutic potential of antibody-oligonucleotide conjugates (AOCs): Current status and future perspectives" [Pharmacol. Res. 209 (2024) 107469].
Pharmacol Res
December 2024
Division of Breast Surgery, Department of General Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008, China. Electronic address:
A multiplex single-cell RNA-Seq pharmacotranscriptomics pipeline for drug discovery.
Nat Chem Biol
October 2024
Disease Networks Unit, Faculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland.
The gene-regulatory dynamics governing drug responses in cancer are yet to be fully understood. Here, we report a pipeline capable of producing high-throughput pharmacotranscriptomic profiling through live-cell barcoding using antibody-oligonucleotide conjugates. This pipeline combines drug screening with 96-plex single-cell RNA sequencing.
View Article and Find Full Text PDFSqueezable Hydrogel Microparticles for Single Extracellular Vesicle Protein Profiling.
Small
October 2024
Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Extracellular vesicles (EVs) are promising for molecular diagnostics, but current analyses are limited by the rarity and compositional heterogeneity of EV protein expression. Therefore, single EV profiling methods require high sensitivity, multiplexing, and throughput to address these issues. Here a single EV analysis technique that utilizes squeezable methacrylated hyaluronic acid hydrogel microparticles (MHPs) is described as a scaffold to immobilize EVs and perform an integrated rolling circle amplification (RCA) assay for an ultra-sensitive and multiplex analysis of single EV proteins.
View Article and Find Full Text PDFOvercoming limitations and advancing the therapeutic potential of antibody-oligonucleotide conjugates (AOCs): Current status and future perspectives.
Pharmacol Res
November 2024
Division of Breast Surgery, Department of General Surgery, Affiliated Drum Tower Hospital, Medical School, Nanjing University, Nanjing 210008, China. Electronic address:
As cancer incidence rises due to an aging population, the importance of precision medicine continues to grow. Antibody-drug conjugates (ADCs) exemplify targeted therapies by delivering cytotoxic agents to specific antigens. Building on this concept, researchers have developed antibody-oligonucleotide conjugates (AOCs), which combine antibodies with oligonucleotides to regulate gene expression.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!